öÏÓãÊÓÆµapp

Skip to main content
You are the owner of this article.
You have permission to edit this article.
Edit

‘Can lead to serious side effects’: Drug recalled in Canada as some bottles may contain wrong pills

A drug used to treat high blood pressure and chest pain has been recalled in Canada.

Insidehaltoncom
1 min to read
Article was updated
JOIN THE CONVERSATION
Health Canada issues public warning over drug recall

Health Canada issued a public advisory over one lot of NRA-Amlodipine 5 mg tablets recalled over bottles that may contain the wrong drug.

Health Canada issued a after a drug used to treat high blood pressure and chest pain as some bottles of the recalled medication may contain the wrong tablets.

One lot of NRA-Amlodipine 5 mg, with the Drug Identification Number (DIN) 02476460, Lot No. EM240229 and expiry date 2027-08, has been impacted by the recall. 

Canada drug recall

NRA-Amlodipine tablets are white or off-white, octagonal, flat and scored in the middle with ‘210’ and ‘5’ on one side. The metoprolol succinate prolonged-release 12.5 mg tablets are white, round and scored in the middle.

ARTICLE CONTINUES BELOW
Product Recall Alert
Never miss important product recall updates!

For locally-based recall alerts, enter the first 3 characters of your postal code. We won't keep this information.

You may unsubscribe at any time. By signing up, you agree to our and . You must be in Canada or the U.S. to sign up.

Evelyn Harford

Evelyn Harford is a reporter on Metroland’s Digital Content Team. Reach Evelyn at eharford@metroland.com.

Join the discussion about this article or read previously posted comments

Recommended For You

More from öÏÓãÊÓÆµappMercury.com & partners

JOIN THE CONVERSATION

To join the conversation set a first and last name in your user profile.

Conversations are opinions of our readers and are subject to the Community Guidelines. öÏÓãÊÓÆµapp Mercury Tribune does not endorse these opinions.